Zahnarzt Perren
  • Willkommen
  • Notfalldienst
  • Praxis
  • Angebot
  • Team
  • Über uns
  • Contact
  • Links
  • Menü Menü
DE | EN | ES | IT | FR | PL | EL | PT

Label: VARDENAFIL HYDROCHLORIDE tablet

Other > vardenafil hcl 10mg


  • 2.2 Use with Food
  • Where can I get more information?
  • What are the Price Projections for Vardenafil Hydrochloride?
  • Vardenafil Warnings/Precautions
  • Vardenafil Pharmacokinetics
  • Affordable men's sexual healthcare you can trust.

These effects were not observed when vardenafil hydrochloride tablets 20 mg were taken 24 hours before the nitroglycerin (NTG). Potentiation of the hypotensive effects of nitrates for patients with ischemic heart disease has not been evaluated, and concomitant use of vardenafil hydrochloride tablets and nitrates is contraindicated [see Contraindications (4.1) and Clinical Pharmacology (12.2).Alpha-Blockers: Caution is advised when PDE5 inhibitors are co-administered with alpha-blockers. PDE5 inhibitors, including vardenafil hydrochloride tablets and alpha-adrenergic blocking agents are both vasodilators with blood-pressure-lowering effects. Clinical pharmacology studies have been conducted with co-administration of vardenafil with alfuzosin, terazosin or tamsulosin. [See Dosage and Administration (2.4), Warnings and Precautions (5.6), and Clinical Pharmacology (12.2).

2.2 Use with Food

What are the most common side effects of vardenafil?

]Antihypertensives: Vardenafil hydrochloride tablets may add to the blood pressure lowering effects of antihypertensive agents. In a clinical pharmacology study of patients with erectile dysfunction, single doses of vardenafil 20 mg caused a mean maximum decrease in supine blood pressure of 7 mmHg systolic and 8 mmHg diastolic (compared to placebo), accompanied by a mean maximum increase of heart rate of 4 beats per minute.

Product Dosage Quantity + Bonus Price
Kamagra Polo100mg180 + 8 Pills446.52€ 425.26€
Cialis Generic40mg270 + 10 Pills382.19€ 363.99€
Kamagra Polo100mg32 Pills125.88€ 119.89€
Levitra Original20mg8 Pills65.05€ 61.95€
Viagra Generic100mg10 Pills28.91€ 27.53€
Super Kamagra160 mg20 + 4 Pills155.35€ 147.95€
Super Kamagra160 mg12 Pills101.10€ 96.29€
Cialis Super Active20mg60 + 8 Pills230.32€ 219.35€
Apcalis SX Oral Jelly20mg120 + 13 Sachets280.38€ 267.03€
Cialis Generic5mg90 + 6 Pills115.91€ 110.39€
Cialis Professional20mg270 + 6 Pills623.07€ 593.40€
Viagra Professional100mg360 + 6 Pills527.09€ 501.99€
Kamagra Soft Tabs100mg180 + 8 Pills425.45€ 405.19€
Viagra Generic50mg90 + 6 Pills107.37€ 102.26€

The maximum decrease in blood pressure occurred between 1 and 4 hours after dosing.

Where can I get more information?

These effects were not observed when vardenafil hydrochloride tablets 20 mg were taken 24 hours before the nitroglycerin (NTG). Potentiation of the hypotensive effects of nitrates for patients with ischemic heart disease has not been evaluated, and concomitant use of vardenafil hydrochloride tablets and nitrates is contraindicated [see Contraindications (4.1) and Clinical Pharmacology (12.2).Alpha-Blockers: Caution is advised when PDE5 inhibitors are co-administered with alpha-blockers. PDE5 inhibitors, including vardenafil hydrochloride tablets and alpha-adrenergic blocking agents are both vasodilators with blood-pressure-lowering effects. Clinical pharmacology studies have been conducted with co-administration of vardenafil with alfuzosin, terazosin or tamsulosin. [See Dosage and Administration (2.4), Warnings and Precautions (5.6), and Clinical Pharmacology (12.2).

Mechanism of Action

]Antihypertensives: Vardenafil hydrochloride tablets may add to the blood pressure lowering effects of antihypertensive agents. In a clinical pharmacology study of patients with erectile dysfunction, single doses of vardenafil 20 mg caused a mean maximum decrease in supine blood pressure of 7 mmHg systolic and 8 mmHg diastolic (compared to placebo), accompanied by a mean maximum increase of heart rate of 4 beats per minute. The maximum decrease in blood pressure occurred between 1 and 4 hours after dosing. Following multiple dosing for 31 days, similar blood pressure responses were observed on Day 31 as on Day 1.Alcohol: Vardenafil hydrochloride tablets (20 mg) did not potentiate the hypotensive effects of alcohol during the 4-hour observation period in healthy volunteers when administered with alcohol (0.5 g/kg body weight, approximately 40 mL of absolute alcohol in a 70 kg person). Alcohol and vardenafil plasma levels were not altered when dosed simultaneously.7.2 Effect of Other Drugs on VardenafilIn vitro studiesStudies in human liver microsomes showed that vardenafil is metabolized primarily by cytochrome P450 (CYP) isoforms 3A4/5, and to a lesser degree by CYP2C9. Following multiple dosing for 31 days, similar blood pressure responses were observed on Day 31 as on Day 1.Alcohol: Vardenafil hydrochloride tablets (20 mg) did not potentiate the hypotensive effects of alcohol during the 4-hour observation period in healthy volunteers when administered with alcohol (0.5 g/kg body weight, approximately 40 mL of absolute alcohol in a 70 kg person). Alcohol and vardenafil plasma levels were not altered when dosed simultaneously.7.2 Effect of Other Drugs on VardenafilIn vitro studiesStudies in human liver microsomes showed that vardenafil is metabolized primarily by cytochrome P450 (CYP) isoforms 3A4/5, and to a lesser degree by CYP2C9. Therefore, inhibitors of these enzymes are expected to reduce vardenafil clearance [see Dosage and Administration (2.4) and Warnings and Precautions (5.2)] .In vivo studiesStrong CYP3A4 inhibitorsKetoconazole (200 mg once daily) produced a 10-fold increase in vardenafil AUC and a 4-fold increase in maximum concentration (C max) when co-administered with vardenafil hydrochloride tablets (5 mg) in healthy volunteers. A 5-mg vardenafil hydrochloride tablet dose should not be exceeded in a 24-hour period when used in combination with 200 mg once daily ketoconazole.

What are the Price Projections for Vardenafil Hydrochloride?

Therefore, inhibitors of these enzymes are expected to reduce vardenafil clearance [see Dosage and Administration (2.4) and Warnings and Precautions (5.2)] .In vivo studiesStrong CYP3A4 inhibitorsKetoconazole (200 mg once daily) produced a 10-fold increase in vardenafil AUC and a 4-fold increase in maximum concentration (C max) when co-administered with vardenafil hydrochloride tablets (5 mg) in healthy volunteers. A 5-mg vardenafil hydrochloride tablet dose should not be exceeded in a 24-hour period when used in combination with 200 mg once daily ketoconazole. Since higher doses of ketoconazole (400 mg daily) may result in higher increases in C sex tablet for men price max and AUC, a single 2.5 mg dose of vardenafil hydrochloride tablets should not be exceeded in a 24-hour period when used in combination with ketoconazole 400 mg daily. [See Dosage and Administration (2.4) and Warnings and Precautions (5). ]Indinavir (800 mg t.i.d.) co-administered with vardenafil hydrochloride tablets 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in vardenafil C max and a 2-fold increase in vardenafil half-life.

What are the serious side effects of vardenafil?

It is recommended not to exceed a single 2.5 mg vardenafil hydrochloride tablets dose in a 24-hour period when used in combination with indinavir. [See Dosage and Administration (2.4) and Warnings and Precautions (5.2). ]Ritonavir (600 mg b.i.d.) co-administered with vardenafil hydrochloride tablets 5 mg resulted in a 49-fold increase in vardenafil AUC and a 13 fold increase in vardenafil C max. The interaction is a consequence of blocking hepatic metabolism of vardenafil by ritonavir, a HIV protease inhibitor and a highly strong CYP3A4 inhibitor, which also inhibits CYP2C9. Ritonavir significantly prolonged the half-life of vardenafil to 26 hours. Since higher doses of ketoconazole (400 mg daily) may result in higher increases in C sex tablet for men price max and AUC, a single 2.5 mg dose of vardenafil hydrochloride tablets should not be exceeded in a 24-hour period when used in combination with ketoconazole 400 mg daily. [See Dosage and Administration (2.4) and Warnings and Precautions (5).

Vardenafil Warnings/Precautions

Consequently, it is recommended not to exceed a single 2.5 mg vardenafil hydrochloride tablets dose in a 72-hour period when used in combination with ritonavir. [See Dosage and Administration (2.4) and Warnings and Precautions (5.2).] .Cobicistat with vardenafil hydrochloride tablets can result in increased plasma concentrations, therefore it is recommended that a single 2.5 mg dose of vardenafil hydrochloride tablets should not be exceeded in a 72-hour period. [See Dosage and Administration (2.4) and Warnings and Precautions (5).] .Moderate CYP3A4 inhibitorsErythromycin (500 mg t.i.d.) produced a 4-fold increase in vardenafil AUC and a 3-fold increase in C max when co administered with vardenafil hydrochloride tablets 5 mg in healthy volunteers. It is recommended not to exceed a single 5 mg dose of vardenafil hydrochloride tablets in a 24-hour period when used in combination with erythromycin. ]Although specific interactions have not been studied, other CYP3A4 inhibitors, including grapefruit juice would likely increase vardenafil exposure.Other Drug InteractionsNo pharmacokinetic interactions were observed between vardenafil and the following drugs: glyburide, warfarin, digoxin, an antacid based on magnesium-aluminum hydroxide, and ranitidine.

Visual disturbances

In the warfarin study, vardenafil had no effect on the prothrombin time or other pharmacodynamic parameters.Cimetidine (400 mg b.i.d.) had no effect on vardenafil bioavailability (AUC) and maximum concentration (C max) of vardenafil when co-administered with 20 mg vardenafil hydrochloride tablets in healthy volunteers.7.3 Effects of Vardenafil on Other DrugsIn vitro studiesVardenafil and its metabolites had no effect on CYP1A2, 2A6, and 2E1 (Ki >100 micromolar). Weak inhibitory effects toward other isoforms (CYP2C8, 2C9, 2C19, 2D6, 3A4) were found, but Ki values were in excess of plasma concentrations achieved following dosing. The most potent inhibitory activity was observed for vardenafil metabolite M1, which had a Ki of 1.4 micromolar toward CYP3A4, which is about 20 times higher than the M1 C max values after an 80 mg vardenafil dose.In vitro data suggest that vardenafil has the potential to inhibit P-glycoprotein (P-gp) at therapeutic doses. While concomitant use of vardenafil hydrochloride tablets did not significantly increase plasma concentrations of digoxin, a P-gp substrate, the effect on plasma concentrations of P-gp substrates that are more sensitive than digoxin (e.g. dabigatran) is not known.In vivo studiesNifedipine: Vardenafil 20 mg, when co-administered with slow-release nifedipine 30 mg or 60 mg once daily, did not affect the AUC or C max of nifedipine, a drug that is metabolized via CYP3A4. ]Indinavir (800 mg t.i.d.) co-administered with vardenafil hydrochloride tablets 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in vardenafil C max and a 2-fold increase in vardenafil half-life. It is recommended not to exceed a single 2.5 mg vardenafil hydrochloride tablets dose in a 24-hour period when used in combination with indinavir. [See Dosage and Administration (2.4) and Warnings and Precautions (5.2). ]Ritonavir (600 mg b.i.d.) co-administered with vardenafil hydrochloride tablets 5 mg resulted in a 49-fold increase in vardenafil AUC and a 13 fold increase in vardenafil C max.

Side Effect Incidence Rate Severity Notes
Headache Common Mild to moderate Usually temporary
Flushing Common Mild Warm sensation
Nasal Congestion Common Mild Sneezing, stuffy nose
Dizziness Less frequent Mild When standing up quickly

The interaction is a consequence of blocking hepatic metabolism of vardenafil by ritonavir, a HIV protease inhibitor and a highly strong CYP3A4 inhibitor, which also inhibits CYP2C9. Ritonavir significantly prolonged the half-life of vardenafil to 26 hours.

  • Vardenafil interacts with certain blood pressure medicines, affecting efficacy.
  • The medication can be used by men of most adult age groups.
  • Women who are pregnant or breastfeeding should not use vardenafil.
  • It’s advisable to avoid grapefruit or grapefruit juice when on vardenafil.
  • Always complete your prescribed course even if symptoms improve.
  • Seek medical attention if you notice symptoms of allergic reaction.
  • Vardenafil is not intended for use by individuals with recent stroke or heart attack.
  • Sexual activity may be dangerous for some men with cardiovascular issues.
  • The medication is not approved for use in women or children.
  • Use caution when combining vardenafil with other erectile dysfunction drugs.

Consequently, it is recommended not to exceed a single 2.5 mg vardenafil hydrochloride tablets dose in a 72-hour period when used in combination with ritonavir.

  • Vardenafil HCl 10mg is used to treat erectile dysfunction in men.
  • It belongs to the phosphodiesterase type 5 inhibitors class.
  • Vardenafil enhances blood flow to the penis during arousal.
  • The usual recommended dose is 10mg taken about 60 minutes before activity.
  • It can be taken with or without food, but high-fat meals may delay effects.
  • Common side effects include headache, flushing, and nasal congestion.
  • Vardenafil is generally safe when used as prescribed by a doctor.
  • Do not combine vardenafil with nitrates or alpha-blockers without medical advice.
  • It may cause dizziness or vision changes; avoid driving if affected.
  • Store vardenafil in a cool, dry place out of reach of children.

[See Dosage and Administration (2.4) and Warnings and Precautions (5.2).] .Cobicistat with vardenafil hydrochloride tablets can result in increased plasma concentrations, therefore it is recommended that a single 2.5 mg dose of vardenafil hydrochloride tablets should not be exceeded in a 72-hour period. [See Dosage and Administration (2.4) and Warnings and Precautions (5).] .Moderate CYP3A4 inhibitorsErythromycin (500 mg t.i.d.) produced a 4-fold increase in vardenafil AUC and a 3-fold increase in C max when co administered with vardenafil hydrochloride tablets 5 mg in healthy volunteers. It is recommended not to exceed a single 5 mg dose of vardenafil hydrochloride tablets in a 24-hour period when used in combination with erythromycin. ]Although specific interactions have not been studied, other CYP3A4 inhibitors, including grapefruit juice would likely increase vardenafil exposure.Other Drug InteractionsNo pharmacokinetic interactions were observed between vardenafil and the following drugs: glyburide, warfarin, digoxin, an antacid based on magnesium-aluminum hydroxide, and ranitidine. In the warfarin study, vardenafil had no effect on the prothrombin time or other pharmacodynamic parameters.Cimetidine (400 mg b.i.d.) had no effect on vardenafil bioavailability (AUC) and maximum concentration (C max) of vardenafil when co-administered with 20 mg vardenafil hydrochloride tablets in healthy volunteers.7.3 Effects of Vardenafil on Other DrugsIn vitro studiesVardenafil and its metabolites had no effect on CYP1A2, 2A6, and 2E1 (Ki >100 micromolar). Weak inhibitory effects toward other isoforms (CYP2C8, 2C9, 2C19, 2D6, 3A4) were found, but Ki values were in excess of plasma concentrations achieved following dosing.

Vardenafil Pharmacokinetics

Nifedipine delayed ejaculation pills did not alter the plasma levels of vardenafil hydrochloride tablets when taken in combination. In these patients whose hypertension was controlled with nifedipine, vardenafil hydrochloride tablets 20 mg produced mean additional supine systolic/diastolic blood pressure reductions of 6/5 mmHg compared to placebo.Ritonavir and Indinavir: Upon concomitant administration of 5 mg of vardenafil hydrochloride tablets with 600 mg BID ritonavir, the C max and AUC of ritonavir were reduced by approximately 20%. Upon administration of 10 mg of vardenafil hydrochloride tablets with 800 mg TID indinavir, the C max and AUC of indinavir were reduced by 40% and 30%, respectively. Nitrates: Concomitant use of vardenafil hydrochloride tablets and nitrates and nitric oxide donors is contraindicated. Potentiation of the hypotensive effects of nitrates for patients with ischemic heart disease has not been evaluated, and concomitant use of vardenafil hydrochloride tablets and nitrates is contraindicated [see Contraindications (4.1) and Clinical Pharmacology (12.2).

What should I tell my healthcare provider before taking vardenafil?

[See Dosage and Administration (2.4), Warnings and Precautions (5.6), and Clinical Pharmacology (12.2).] Antihypertensives: Vardenafil hydrochloride tablets may add to the blood pressure lowering effects of antihypertensive agents. Following multiple dosing for 31 days, similar blood pressure responses were observed on Day 31 as on Day 1. Alcohol: Vardenafil hydrochloride tablets (20 mg) did not potentiate the hypotensive effects of alcohol during the 4-hour observation period in healthy volunteers when administered with alcohol (0.5 g/kg body weight, approximately 40 mL of absolute alcohol in a 70 kg person). Alcohol and vardenafil plasma levels were not altered when dosed simultaneously. Studies in human liver microsomes showed that vardenafil is metabolized primarily by cytochrome P450 (CYP) isoforms 3A4/5, and to a lesser degree by CYP2C9. The most potent inhibitory activity was observed for vardenafil metabolite M1, which had a Ki of 1.4 micromolar toward CYP3A4, which is about 20 times higher than the M1 C max values after an 80 mg vardenafil dose.In vitro data suggest that vardenafil has the potential to inhibit P-glycoprotein (P-gp) at therapeutic doses. While concomitant use of vardenafil hydrochloride tablets did not significantly increase plasma concentrations of digoxin, a P-gp substrate, the effect on plasma concentrations of P-gp substrates that are more sensitive than digoxin (e.g. dabigatran) is not known.In vivo studiesNifedipine: Vardenafil 20 mg, when co-administered with slow-release nifedipine 30 mg or 60 mg once daily, did not affect the AUC or C max of nifedipine, a drug that is metabolized via CYP3A4. Nifedipine delayed ejaculation pills did not alter the plasma levels of vardenafil hydrochloride tablets when taken in combination. In these patients whose hypertension was controlled with nifedipine, vardenafil hydrochloride tablets 20 mg produced mean additional supine systolic/diastolic blood pressure reductions of 6/5 mmHg compared to placebo.Ritonavir and Indinavir: Upon concomitant administration of 5 mg of vardenafil hydrochloride tablets with 600 mg BID ritonavir, the C max and AUC of ritonavir were reduced by approximately 20%. Upon administration of 10 mg of vardenafil hydrochloride tablets with 800 mg TID indinavir, the C max and AUC of indinavir were reduced by 40% and 30%, respectively. Nitrates: Concomitant use of vardenafil hydrochloride tablets and nitrates and nitric oxide donors is contraindicated.

Affordable men's sexual healthcare you can trust.

Therefore, inhibitors of these enzymes are expected to reduce vardenafil clearance [see Dosage and Administration (2.4) and Warnings and Precautions (5.2)] . Ketoconazole (200 mg once daily) produced a 10-fold increase in vardenafil AUC and a 4-fold increase in maximum concentration (C max) when co-administered with vardenafil hydrochloride tablets (5 mg) in healthy volunteers. [See Dosage and Administration (2.4) and Warnings and Precautions (5).] Indinavir (800 mg t.i.d.) co-administered with vardenafil hydrochloride tablets 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in vardenafil C max and a 2-fold increase in vardenafil half-life. [See Dosage and Administration (2.4) and Warnings and Precautions (5.2).] Ritonavir (600 mg b.i.d.) co-administered with vardenafil hydrochloride tablets 5 mg resulted in a 49-fold increase in vardenafil AUC and a 13 fold increase in vardenafil C max. [See Dosage and Administration (2.4) and Warnings and Precautions (5.2).].

DescriptionSources:&nbsphttp://www.drugbank.ca/drugs/DB00862Curator's Comment:&nbspDescription was created based on several sources, including http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021400s017lbl.pdf

Cobicistat with vardenafil hydrochloride tablets can result in increased plasma concentrations, therefore it is recommended that a single 2.5 mg dose of vardenafil hydrochloride tablets should not be exceeded in a 72-hour period. [See Dosage and Administration (2.4) and Warnings and Precautions (5).]. Erythromycin (500 mg t.i.d.) produced a 4-fold increase in vardenafil AUC and a 3-fold increase in C max when co administered with vardenafil hydrochloride tablets 5 mg in healthy volunteers. [See Dosage and Administration (2.4) and Warnings and Precautions (5).] Although specific interactions have not been studied, other CYP3A4 inhibitors, including grapefruit juice would likely increase vardenafil exposure. Potentiation of the hypotensive effects of nitrates for patients with ischemic heart disease has not been evaluated, and concomitant use of vardenafil hydrochloride tablets and nitrates is contraindicated [see Contraindications (4.1) and Clinical Pharmacology (12.2). [See Dosage and Administration (2.4), Warnings and Precautions (5.6), and Clinical Pharmacology (12.2).] Antihypertensives: Vardenafil hydrochloride tablets may add to the blood pressure lowering effects of antihypertensive agents. Following multiple dosing for 31 days, similar blood pressure responses were observed on Day 31 as on Day 1. Alcohol: Vardenafil hydrochloride tablets (20 mg) did not potentiate the hypotensive effects of alcohol during the 4-hour observation period in healthy volunteers when administered with alcohol (0.5 g/kg body weight, approximately 40 mL of absolute alcohol in a 70 kg person).

Drug Class Interaction Type Effect Recommendation
Nitrates Additive hypotension Risk of severe low blood pressure Do not combine
CYP3A4 inhibitors Increased Vardenafil levels Potential side effects Adjust dosage if necessary
Alpha-blockers Enhanced hypotensive effect Dizziness, fainting Use with caution
Alpha-adrenergic agents Blood pressure changes Fluctuations in BP Monitor blood pressure closely

Alcohol and vardenafil plasma levels were not altered when dosed simultaneously. Studies in human liver microsomes showed that vardenafil is metabolized primarily by cytochrome P450 (CYP) isoforms 3A4/5, and to a lesser degree by CYP2C9. Therefore, inhibitors of these enzymes are expected to reduce vardenafil clearance [see Dosage and Administration (2.4) and Warnings and Precautions (5.2)] . Ketoconazole (200 mg once daily) produced a 10-fold increase in vardenafil AUC and a 4-fold increase in maximum concentration (C max) when co-administered with vardenafil hydrochloride tablets (5 mg) in healthy volunteers. [See Dosage and Administration (2.4) and Warnings and Precautions (5).] Indinavir (800 mg t.i.d.) co-administered with vardenafil hydrochloride tablets 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in vardenafil C max and a 2-fold increase in vardenafil half-life. [See Dosage and Administration (2.4) and Warnings and Precautions (5.2).] Ritonavir (600 mg b.i.d.) co-administered with vardenafil hydrochloride tablets 5 mg resulted in a 49-fold increase in vardenafil AUC and a 13 fold increase in vardenafil C max. [See Dosage and Administration (2.4) and Warnings and Precautions (5.2).].

Point Explanation Additional Advice
Take as prescribed Usually 10 mg about 30-60 min before activity Do not exceed recommended dose
Food interactions High-fat meals may delay onset Take on an empty stomach or low-fat meal
Alcohol consumption May decrease effectiveness or increase side effects Limit alcohol intake
Report side effects or adverse reactions Such as vision changes, pain, prolonged erections Seek medical attention immediately

Cobicistat with vardenafil hydrochloride tablets can result in increased plasma concentrations, therefore it is recommended that a single 2.5 mg dose of vardenafil hydrochloride tablets should not be exceeded in a 72-hour period. [See Dosage and Administration (2.4) and Warnings and Precautions (5).]. Erythromycin (500 mg t.i.d.) produced a 4-fold increase in vardenafil AUC and a 3-fold increase in C max when co administered with vardenafil hydrochloride tablets 5 mg in healthy volunteers. [See Dosage and Administration (2.4) and Warnings and Precautions (5).] Although specific interactions have not been studied, other CYP3A4 inhibitors, including grapefruit juice would likely increase vardenafil exposure.

  • Vardenafil HCl 10mg can be an effective treatment when used responsibly.
  • Always follow the prescribed dosing schedule for safety and efficacy.
  • The medication may need to be adjusted based on individual response.
  • Use with caution if you have a history of cardiovascular disease.
  • Discuss all current medications with your doctor to avoid interactions.
  • Vardenafil is not recommended for use by women or children.
  • Be aware of possible side effects and seek medical help when needed.
  • Alcohol and fatty foods can interfere with the drug’s performance.
  • Proper sexual stimulation is required for the drug to work effectively.
  • Regular follow-up with your healthcare provider is encouraged.
  • Super P Force Tablets
  • Vigora Oral Jelly
  • Cost and Availability of Generic Sildenafil Fildena
  • The Mechanism of Action: How Sildenafil Works
  • Potential Side Effects of Generic Cialis and Safety Information
  • VARDENAFIL BIOGARAN 10 mg cp
  • Fármacos para la erección más allá de sildenafilo: tadalafilo, vardenafilo y avanafilo

ZurückWeiter
123

In der Zahnarztpraxis Perren an der Bahnhofstrasse 4A in Brig-Glis finden sie die optimalen Voraussetzungen für eine nachhaltige Behandlung: Unser bestens qualifiziertes Team, modernste Ausrüstung sowie die Verwendung hochwertigster Materialien garantieren Ihnen Zahnmedizin gemäss dem neuesten Stand der Technik und auf höchstem Qualitätsniveau.

© Zahnarztpraxis Perren

  • Rechtliches
  • Privacy
  • Imprint
Nach oben scrollen

Diese Website verwendet Cookies.

EinverstandenInformationen

Cookie- und Datenschutzeinstellungen



Wie wir Cookies verwenden

Wir können Cookies anfordern, die auf Ihrem Gerät eingestellt werden. Wir verwenden Cookies, um uns mitzuteilen, wenn Sie unsere Websites besuchen, wie Sie mit uns interagieren, Ihre Nutzererfahrung verbessern und Ihre Beziehung zu unserer Website anpassen.

Klicken Sie auf die verschiedenen Kategorienüberschriften, um mehr zu erfahren. Sie können auch einige Ihrer Einstellungen ändern. Beachten Sie, dass das Blockieren einiger Arten von Cookies Auswirkungen auf Ihre Erfahrung auf unseren Websites und auf die Dienste haben kann, die wir anbieten können.

Notwendige Website Cookies

Diese Cookies sind unbedingt erforderlich, um Ihnen die auf unserer Webseite verfügbaren Dienste und Funktionen zur Verfügung zu stellen.

Da diese Cookies für die auf unserer Webseite verfügbaren Dienste und Funktionen unbedingt erforderlich sind, hat die Ablehnung Auswirkungen auf die Funktionsweise unserer Webseite. Sie können Cookies jederzeit blockieren oder löschen, indem Sie Ihre Browsereinstellungen ändern und das Blockieren aller Cookies auf dieser Webseite erzwingen. Sie werden jedoch immer aufgefordert, Cookies zu akzeptieren / abzulehnen, wenn Sie unsere Website erneut besuchen.

Wir respektieren es voll und ganz, wenn Sie Cookies ablehnen möchten. Um zu vermeiden, dass Sie immer wieder nach Cookies gefragt werden, erlauben Sie uns bitte, einen Cookie für Ihre Einstellungen zu speichern. Sie können sich jederzeit abmelden oder andere Cookies zulassen, um unsere Dienste vollumfänglich nutzen zu können. Wenn Sie Cookies ablehnen, werden alle gesetzten Cookies auf unserer Domain entfernt.

Wir stellen Ihnen eine Liste der von Ihrem Computer auf unserer Domain gespeicherten Cookies zur Verfügung. Aus Sicherheitsgründen können wie Ihnen keine Cookies anzeigen, die von anderen Domains gespeichert werden. Diese können Sie in den Sicherheitseinstellungen Ihres Browsers einsehen.

Andere externe Dienste

Wir nutzen auch verschiedene externe Dienste wie Google Webfonts, Google Maps und externe Videoanbieter. Da diese Anbieter möglicherweise personenbezogene Daten von Ihnen speichern, können Sie diese hier deaktivieren. Bitte beachten Sie, dass eine Deaktivierung dieser Cookies die Funktionalität und das Aussehen unserer Webseite erheblich beeinträchtigen kann. Die Änderungen werden nach einem Neuladen der Seite wirksam.

Google Webfont Einstellungen:

Google Maps Einstellungen:

Google reCaptcha Einstellungen:

Vimeo und YouTube Einstellungen:

Datenschutzrichtlinie

Sie können unsere Cookies und Datenschutzeinstellungen im Detail in unseren Datenschutzrichtlinie nachlesen.

Privacy
Einstellungen akzeptierenVerberge nur die Benachrichtigung